Pfizer has reported results for first quarter ended June 30, 2021.
The company has reported a rise of 60.63% in its net profit at Rs 199.91 crore for the quarter under review as compared to Rs 124.45 crore for the same quarter in the previous year. Total income of the company increased by 43.10% at Rs 761.41 crore for Q1FY22 as compared Rs 532.09 crore for the corresponding quarter previous year.
Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 687.55 |
Dr. Reddy's Lab | 4730.20 |
Lupin | 1105.80 |
Cadila Healthcare | 577.85 |
Aurobindo Pharma | 915.15 |
View more.. |